All Posts Tagged With: "eli lilly"

Global Investing Roundups

S&P Slashes RBS Rating; Dendreon’s Big Boost; Eli Lilly Comes Out Ahead on ImClone; AgFeed’s Hungry For Its Own Shares; Bank of America Surprises with Loss; Paulson Taps Another Goldman Exec.

7Oct2008 | Money Morning | Comments Off | Continued

Monsanto Sells Off Controversial Milk-Hormone Unit to Focus on Seed Product Lines

Monsanto Co. (MON), the world’s largest seed producer, is selling off its rights to a synthetic milk-producing hormone in order to focus its attention more closely on its core business of developing genetically modified seeds and pesticides.

U.S. pharmaceutical company Eli Lilly & Co. (LLY) will pay Monsanto $300 million for Posilac, the brand name for recombinant bovine somatotropin or rBST. The deal includes the global sale rights and a Georgia-based manufacturing plant.

Lilly has been distributing Posilac, which has been on the market since 1994, for Monsanto under an exclusive agreement and hopes this deal will enable it to expand…

21Aug2008 | Money Morning | Comments Off | Continued
  • Polls

    How Has The U.S. Recession Affected You?

    View Results

    Loading ... Loading ...
  • Improve the web with Nofollow Reciprocity.